BioMarin Pharmaceutical, Inc. (BMRN)
65.04
-1.66
(-2.50%)
USD |
NASDAQ |
Aug 24, 16:00
65.04
0.00 (0.00%)
After-Hours: 20:00
BioMarin Pharmaceutical Total Return Level : 66.70 for Aug. 21, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 21, 2026 | 66.70 |
| August 20, 2026 | 67.68 |
| August 19, 2026 | 69.33 |
| August 18, 2026 | 66.99 |
| August 17, 2026 | 66.64 |
| August 14, 2026 | 67.36 |
| August 13, 2026 | 68.53 |
| August 12, 2026 | 70.24 |
| August 11, 2026 | 69.55 |
| August 10, 2026 | 68.88 |
| August 07, 2026 | 63.81 |
| August 06, 2026 | 61.46 |
| August 05, 2026 | 59.91 |
| August 04, 2026 | 60.72 |
| August 03, 2026 | 60.00 |
| July 31, 2026 | 60.02 |
| July 30, 2026 | 60.58 |
| July 29, 2026 | 61.37 |
| July 28, 2026 | 62.07 |
| July 27, 2026 | 60.27 |
| July 24, 2026 | 59.33 |
| July 23, 2026 | 58.87 |
| July 22, 2026 | 58.40 |
| July 21, 2026 | 59.21 |
| July 20, 2026 | 59.11 |
| Date | Value |
|---|---|
| July 17, 2026 | 59.59 |
| July 16, 2026 | 60.00 |
| July 15, 2026 | 58.95 |
| July 14, 2026 | 58.64 |
| July 13, 2026 | 59.20 |
| July 10, 2026 | 59.12 |
| July 09, 2026 | 59.97 |
| July 08, 2026 | 59.75 |
| July 07, 2026 | 60.35 |
| July 06, 2026 | 58.79 |
| July 02, 2026 | 58.99 |
| July 01, 2026 | 57.82 |
| June 30, 2026 | 57.22 |
| June 29, 2026 | 57.67 |
| June 26, 2026 | 59.00 |
| June 25, 2026 | 57.35 |
| June 24, 2026 | 57.33 |
| June 23, 2026 | 56.50 |
| June 22, 2026 | 55.90 |
| June 18, 2026 | 54.69 |
| June 17, 2026 | 55.02 |
| June 16, 2026 | 55.12 |
| June 15, 2026 | 55.65 |
| June 12, 2026 | 55.95 |
| June 11, 2026 | 55.54 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Incyte Corp. | 127.81 |
| Alnylam Pharmaceuticals, Inc. | 236.22 |
| Vertex Pharmaceuticals, Inc. | 548.05 |
| Ionis Pharmaceuticals, Inc. | 59.74 |
| Regeneron Pharmaceuticals, Inc. | 841.77 |